MARKET

HRTX

HRTX

Heron Therapeutics Inc
NASDAQ
0.2930
+0.0130
+4.64%
After Hours: 0.2900 -0.003 -1.02% 18:04 11/06 EST
OPEN
0.2816
PREV CLOSE
0.2800
HIGH
0.2958
LOW
0.2766
VOLUME
1.17M
TURNOVER
--
52 WEEK HIGH
1.575
52 WEEK LOW
0.2610
MARKET CAP
55.63M
P/E (TTM)
-1.5421
1D
5D
1M
3M
1Y
5Y
1D
Heron Therapeutics Q3 Earnings Preview
Seeking Alpha · 1d ago
Largest borrow rate increases among liquid names
TipRanks · 2d ago
Xencor (XNCR) Q3 Earnings and Revenues Beat Estimates
NASDAQ · 3d ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 3d ago
Weekly Report: what happened at HRTX last week (1026-1030)?
Weekly Report · 6d ago
Russell 2000 estimated to drop 83 stocks in December rebalance - Stephens
Seeking Alpha · 10/29 19:44
Weekly Report: what happened at HRTX last week (1019-1023)?
Weekly Report · 10/26 09:35
CytoDyn Appoints Robert E. Hoffman As CEO; Lalezari To Focus On Research
NASDAQ · 10/20 07:28
More
About HRTX
Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutics that improve medical care. Its acute care product portfolio includes ZYNRELEF, APONVIE, CINVANTI, and SUSTOL. ZYNRELEF is a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low-dose of the nonsteroidal anti-inflammatory drug meloxicam. APONVIE is the intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist indicated for postoperative nausea and vomiting in adults. CINVANTI is an IV formulation of aprepitant, a substance NK1 receptor antagonist. SUSTOL is the first extended-release 5-HT3 receptor antagonist approved for the prevention of acute and delayed nausea and vomiting associated with both MEC and anthracycline and cyclophosphamide combination chemotherapy regimens.

Webull offers Heron Therapeutics Inc stock information, including NASDAQ: HRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HRTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HRTX stock methods without spending real money on the virtual paper trading platform.